Anaptysbio (ANAB) Other Operating Expenses (2023)

Anaptysbio (ANAB) posted Other Operating Expenses of $7.3 million for Q4 2023.

Anaptysbio (ANAB) Other Operating Expenses (2023) Analysis & Trends

Anaptysbio's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $7.3 million for Q4 2023.

Quarterly Other Operating Expenses changed N/A year-over-year to $7.3 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $7.3 million (changed N/A YoY) and the FY2023 annual result came in at $7.3 million, changed N/A from the prior year.
Other Operating Expenses was $7.3 million for Q4 2023 at Anaptysbio.
Across five years, Other Operating Expenses topped out at $7.3 million in Q4 2023 and bottomed at $7.3 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Anaptysbio	1.58 Bn	1.29 Bn	-

Download Data

Date	Value
Dec 31, 2023	7.34 Mn